Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Rodloff

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 1, 1992
German multicentre study on the in vitro susceptibility of Bacteroides species. The German Bacteroides Study GroupA C Rodloff, H Werner, M Kresken, et al.
Infection|November 1, 2005
Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar platesR Schaumann, S Petzold, M Fille, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Comparative in vitro activities of gemifloxacin, other quinolones, and nonquinolone antimicrobials against obligately anaerobic bacteriaN Kleinkauf, G Ackermann, R Schaumann, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|November 1, 1986
Effects of anti-Bacteroides-antibodies on Escherichia coli and different Bacteroides species in vitro and vivoA C Rodloff, F Hilliger, H Friedman, et al.
The Journal of Antimicrobial Chemotherapy|September 26, 2006
Two decades of imipenem therapyA C Rodloff, E J C Goldstein, A Torres
Antimicrobial Agents and Chemotherapy|October 25, 2003
In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteriaA Liebetrau, A C Rodloff, J Behra-Miellet, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
Alterations of responses to bacterial endotoxin by Bacteroides fragilis in vivo and in vitroA C Rodloff, S Ehlers, D K Blanchard, et al.
Infection|September 8, 2001
Infections caused by Stenotrophomonas maltophilia--a prospective studyR Schaumann, K Stein, C Eckhardt, et al.
European Journal of Medical Research|November 19, 2002
Effects of Porphyromonas gingivalis on the activation of mouse macrophages by lipopolysaccharideReiner Schaumann, K Sommer, C Retzlaff, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 7, 2012
First- and second-line anti-tuberculosis drug resistance in Northwest EthiopiaB Tessema, J Beer, F Emmrich, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 1, 1992
German multicentre study on the in vitro susceptibility of Bacteroides species. The German Bacteroides Study GroupA C Rodloff, H Werner, M Kresken, et al.
Infection|November 1, 2005
Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar platesR Schaumann, S Petzold, M Fille, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Comparative in vitro activities of gemifloxacin, other quinolones, and nonquinolone antimicrobials against obligately anaerobic bacteriaN Kleinkauf, G Ackermann, R Schaumann, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|November 1, 1986
Effects of anti-Bacteroides-antibodies on Escherichia coli and different Bacteroides species in vitro and vivoA C Rodloff, F Hilliger, H Friedman, et al.
The Journal of Antimicrobial Chemotherapy|September 26, 2006
Two decades of imipenem therapyA C Rodloff, E J C Goldstein, A Torres
Antimicrobial Agents and Chemotherapy|October 25, 2003
In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteriaA Liebetrau, A C Rodloff, J Behra-Miellet, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
Alterations of responses to bacterial endotoxin by Bacteroides fragilis in vivo and in vitroA C Rodloff, S Ehlers, D K Blanchard, et al.
Infection|September 8, 2001
Infections caused by Stenotrophomonas maltophilia--a prospective studyR Schaumann, K Stein, C Eckhardt, et al.
European Journal of Medical Research|November 19, 2002
Effects of Porphyromonas gingivalis on the activation of mouse macrophages by lipopolysaccharideReiner Schaumann, K Sommer, C Retzlaff, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 7, 2012
First- and second-line anti-tuberculosis drug resistance in Northwest EthiopiaB Tessema, J Beer, F Emmrich, et al.
Pageof 8